Synchronous Multiple Primary Lung Cancer 동시에 여러 곳에서 폐암이 생겨나? Introduction Second primary tumors - ‘Synchronous’ : Detected or resected simultaneously - ‘Metachronous’ : Detected some time after the primary lesion Incidence of synchronous lung cancers - ranges from 0.2% to 8% (3.5%-14% in autopsy studies) - Around 900,000 new multiple cancer cases globally (8% of 10,900,000) - Age 50-64 : 5~12% /..
만성폐쇄성 폐질환 (COPD) GOLD 가이드라인 2017 GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE(GOLD) 2017 COPD Definition Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles..
소세포 폐암 (SCLC) 의 치료 Small-cell lung cancer (SCLC) - 13–15% of newly diagnosed lung cancer per year. - Most patients present with extensive stage disease --> expected survival : 2~4 months without Tx. Five year survival rates - Limited-stage SCLC : 10–13% - Extensive-stage SCLC : 1–2% WHO classification - 2 types of SCLC : pure and combined - Up to 28% may present with combined SCLC histology SCLC..
복수의 치료, 간성 흉수의 치료 Treatment of Ascites, Hepatic hydrothorax Ascites 의 pathophysiology - 문맥압 상승 --> 국소 혈관 확장 물질 생성 증가 (주로 NO) --> Splanchnic arterial vasodilatation --> Effective arterial blood volume 의 저하 --> 교감신경계, RAAS 항진, ADH 증가 --> 신장에서의 Na 저류, 세포외액 증가 --> 복수, 부종, Hyponatremia 발생. Hepatic hydrothorax 란? Presence of a pleural effusion in a patient with cirrhosis - does not have other reasons ..
